Current Cancer Drug Targets
Title:Meet Our Editorial Board Member
Volume: 17 Issue: 6
Author(s): G. S.W. Tsao*
Affiliation:
- University of Hong Kong Hong Kong,China
Export Options
About this article
Cite this article as:
Tsao S.W. G.*, Meet Our Editorial Board Member, Current Cancer Drug Targets 2017; 17 (6) . https://dx.doi.org/10.2174/156800961706170630192321
DOI https://dx.doi.org/10.2174/156800961706170630192321 |
Print ISSN 1568-0096 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5576 |
10
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Traditional Uses, Phytochemistry, Pharmacology and Anticancer Activity
of Açaí (Euterpe oleracea Mart): A Narrative Review
Current Traditional Medicine Opportunities and Challenges for Host-Directed Therapies in Tuberculosis
Current Pharmaceutical Design Gonadotropin-Releasing Hormone (GnRH) Receptors in Tumors: a New Rationale for the Therapeutical Application of GnRH Analogs in Cancer Patients?
Current Cancer Drug Targets Aluminofluoride Complexes: Phosphate Analogues and a Hidden Hazard for Living Organisms
Current Inorganic Chemistry (Discontinued) Calcium and Zinc DTPA Administration for Internal Contamination with Plutonium-238 and Americium-241
Current Pharmaceutical Biotechnology Prevention and Treatment of Bone Metastases
Current Pharmaceutical Design Enhanced Antisense Oligonucleotide Delivery Using Cationic Liposomes Incorporating Fatty Acid-Modified Polyethylenimine
Current Pharmaceutical Biotechnology The Bioreactor: A Powerful Tool for Large-Scale Culture of Animal Cells
Current Pharmaceutical Biotechnology Gab1, SHP-2 and Other Novel Regulators of Ras: Targets for Anticancer Drug Discovery?
Current Cancer Drug Targets Apoptosis and Acute Brain Ischemia in Ischemic Stroke
Current Vascular Pharmacology Targeting Platinum Resistant Disease in Ovarian Cancer
Current Medicinal Chemistry Chalcone Derivatives Activate and Desensitize the Transient Receptor Potential Ankyrin 1 Cation Channel, Subfamily A, Member 1 TRPA1 Ion Channel: Structure-Activity Relationships in vitro and Anti-Nociceptive and Anti-inflammatory Activity in vivo
CNS & Neurological Disorders - Drug Targets Light Directed Gene Transfer by Photochemical Internalisation
Current Gene Therapy Novel Drugs Targeting Microtubules: the Role of Epothilones
Current Pharmaceutical Design An Overview of the α4β1 Integrin and the Potential Therapeutic Role of its Antagonists
Current Medicinal Chemistry Optical Image-Guided Cancer Therapy
Current Pharmaceutical Biotechnology The Hedgehog Knows Many Tricks
Current Drug Targets Upregulation of DLX2 Confers a Poor Prognosis in Glioblastoma Patients by Inducing a Proliferative Phenotype
Current Molecular Medicine An Expanding Appreciation of the Role Chemokine Receptors Play in Cancer Progression
Current Pharmaceutical Design Stress Related Neuroendocrine Influences in Ovarian Cancer
Current Cancer Therapy Reviews